- Display 15 Products per page
Emerging Infectious Disease Diagnostics: Markets and Trends
Published: May 27, 2020 | Price: $3,000.00 – $6,000.00
In light of the COVID-19 (coronavirus) pandemic, it is extremely timely to present a report on the status quo in emerging infectious diseases. While the current pandemic is troublesome and has disrupted normal life, it will follow its course and then fade away. Where could the next pandemic or epidemic come from? There are a number of diseases currently tracking as moving from the developed world to the developing world? Kalorama has addressed emerging infectious disease since our first study nine...
Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
Published: June 1, 2009 | Price: $3,995.00 – $7,990.00
The global market for human vaccines has experienced strong growth through 2008 and this is expected to continue through the forecast period. Growth will be fueled by new product introductions and rising usage in all regions. This report, Vaccines 2009: Key Players, and Critical Trends in a Fast-Changing Industry), examines the market for vaccines used in humans to previous various types of disease. Sales estimates for each market segment represent global revenues and are expressed in current dollars. Estimates are...
World Wound Care Markets 2008 (Sales and Key Trends in the Treatment of Burns, Skin Ulcers, Surgical and Trauma Wounds)
Published: May 1, 2008 | Price: $995.00 – $5,600.00
2008 has seen no decrease in attention on wound care products. The aging of the population and a constant demand for products that speed healing and improve outcomes drives the wound care industry. For market watchers, this makes for a dynamic market that has changed in recent years with biological developments. Kalorama Information's analyst Mary Ann Crandall has reviewed the Wound Care Industry in several editions of wound care market reports and has participated in industry panels. Kalorama Information's three-volume...
Complex Regional Pain Syndrome (CRPS) – A Market Briefing
Published: August 1, 2005 | Price: $795.00 – $1,990.00
Neurological disease that impacts the sensory pathway can produce severe chronic pain, also known as neuropathic pain. This usually is unrelated to any peripheral tissue injury. This occurs with disorders of the central nervous system (CNS), such as stroke and multiple sclerosis, or with conditions associated with peripheral nerve damage, such as mechanical injury, diabetic neuropathy or herpes zoster infection. On form of neuropathic pain that is just now gaining recognistino is complex regional pain syndrome (CRPS), also known as...
Current IVD Market Trends
Published: October 31, 2019 | Price: $3,000.00 – $6,000.00
This report is an update on the worldwide in vitro diagnostics (IVD) market, examining several of the factors that currently contribute to the evolving IVD market picture. The topics discussed are the following: The Worldwide IVD Market, 2019-2024 Market Developments in Selected Markets – North America, EU15/Western Europe, Eastern Europe, Japan and China Genetic Testing New POC Innovations Cancer Testing and Personalized Medicine Hematology Glucose Monitoring Advancements HbA1c Testing New Developments in Infectious Diseases Cytology - Increasing Molecular Dx Options...
Men’s Health: The World Market for Current and Emerging Drug Therapies
Published: August 1, 2003 | Price: $2,625.00 – $5,250.00
This Kalorama Information report—Men’s Health: The World Market for Current and Emerging Drug Therapies—focuses on treatment segments in which men are affected. These segments include: · Men’s Cancer · Sexual Function · Sexually Transmitted Diseases · Urinary Conditions · Andropause The report covers drugs that are used for the treatment of conditions affecting men, including prostate cancer, impotence, and BPH; and areas where diseases and men’s health are a major concern including HIV, herpes, and urinary incontinence. Revenues for product...
The Worldwide Market for Point-of-Care (POC) Diagnostics, 7th Edition (Infectious Disease Testing, Cancer Point of Care, Rapid Coagulation, Urine Testing, Lipids, Pregnancy, Glucose and Other Tests)
Published: March 17, 2020 | Price: $5,500.00 – $11,000.00
This report represents the 7th edition of a fast-growing and competitive category of the in vitro diagnostic market. Point-of-care (POC) tests are diagnostics performed outside the central laboratory or executed via decentralized testing. POC testing has skyrocketed in the last 20 years as demand for accurate and fast testing has grown both inside and outside the hospital setting. The increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to...
2021 IVD Market Update and COVID-19 Impact
Published: March 12, 2021 | Price: $3,000.00 – $6,000.00
What is the Size of the IVD Market in 2021? What Impact has COVID-19 Had on IVD Markets? What Major Trends are Affecting the Market in 2021? Diagnostic test products have never been more important. This report, 2021 IVD Market Update and COVID-19 Impact, is an update of the market for in vitro diagnostics products from Kalorama's analysts to reflect the latest information. As part of its coverage, this report contains market sizing for the following categories of IVD: Clinical...
Worldwide Sequencer Market, 2023-2028
Published: August 8, 2024 | Price: $5,000.00 – $10,500.00
Kalorama Information’s new comprehensive report, Worldwide Sequencer Market, 2023-2028, provides an in-depth analysis of the sequencing market, highlighting key trends, challenges, strategies, companies, and products. The report includes detailed market share estimates, revenue growth forecasts, and a thorough examination of the competitive landscape, featuring significant deals and products. The report offers historical data for 2023 and forecast data through 2028, focusing on the market for sequencing systems and products. This encompasses systems, consumables, software, and system servicing, related to the...
The IVD Market in South Korea
Published: September 13, 2018 | Price: $2,500.00 – $5,000.00
The IVD Market in South Korea The IVD Market in South Korea provides an overview of the in vitro diagnostics market in South Korea and its influences. The focus is on the following IVD market sub-segments: clinical chemistry, immunoassays, microbiology and molecular testing, point-of-care testing, and histology/cytology. The market data provided give an overview of developments in the in vitro diagnostics industry in South Korea, presenting IVD revenues by extracted market segment for 2017 and 2022, which includes general chemistry,...
Analytical Chip Technology – U.S. Markets for Lab on a Chip, DNA/Gene, Protein, and other Microarrays, 3rd. Edition
Published: November 1, 2007 | Price: $995.00 – $5,495.00
Analytical microchips can be considered one of the fastest growing technology segments in life sciences. The range of applications to which these miniature laboratories may be directed is very broad — covering fields as different as pharmaceutical development, food testing, clinical diagnostics, forensics, and environmental analysis. Kalorama's Analytical Chip Technology: U.S. Markets for Lab on a Chip, DNA/Gene, Protein and other Microarrasys) 3rd. Edition looks at the market for analytical microchips with a unique methodology -- the market is expressed...
Stem Cell Therapeutics Markets
Published: February 1, 2009 | Price: $995.00 – $5,000.00
Political and business events presage change for stem cell therapeutics, most notably the expected move by President Barack Obama to lift federal funding restrictions on stem-cell research. The U.S. Congress has also indicated a desire to move forward with stem cell research. The momentum in two branches of American government, along with scientific developments and the competition of world markets presages good market conditions for stem cell research. With their ability to differentiate and become an ongoing source of cells...
The World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition
Published: September 22, 2013 | Price: $2,995.00 – $6,000.00
The World Market for Biosimlars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition This study, The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others), is designed to provide a comprehensive look at the various strategies being used by select worldwide generic companies in exploring the emerging area of biosimilars, the issues and trends that are shaping the marketplace, and the potential feasibility of providing biosimilars within the United States regulatory environment....
OEM Contract Manufacturing in Medical Devices, Vol II – Electronics and Advanced Systems
Published: October 1, 2007 | Price: $1,995.00 – $6,990.00
Abundant opportunities are available for electronics and advanced systems companies who enter the outsourcing medical device manufacturing market; but the market is competitive and information has been hard to obtain. Contract Manufacturers(CMs) are finding opportunities with managers located at the corporate headquarters or main manufacturing/assembly operations as they take a hard look at costs and seek outsourcing for cost efficiency. Kalorama's OEM Contract Manufacturing in Medical Devices Series presents a total study of market for outsourcing in medical devices. It...
Outsourcing in Drug Development: The Contract CRO Market, 3rd Edition
Published: October 1, 2008 | Price: $3,500.00 – $7,000.00
Driven by mounting market pressures, companies are increasingly implementing outsourcing strategies to increase revenues through faster drug development. By decreasing their in-house facilities and staff, and outsourcing more of their R&D functions, pharmaceutical and biotechnology companies are reshaping the drug development services industry. Kalorama Information's Outsourcing in Drug Development is the third edition of this study of the drivers for outsourcing drug development, the companies involved in this market and the opportunity for revenues. Part of the CMO Market Series,...